US 11,883,029 · Application 17/867,990 · Granted Jan 30, 2024
US 11,883,029
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
Estimated expiration
September 10, 2022
Expired 1478 days ago
Earliest effective filing
Sep 10, 2002
+ 20 years
Sep 10, 2022
PTA +0d
Sep 10, 2022
TD applied
Sep 10, 2022
Final
Sep 10, 2022
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- July 19, 2022
- Earliest effective filing
- September 10, 2002
- Issue date
- January 30, 2024
- PTA
- 0 days
- Base expiry (before PTA)
- September 10, 2022
September 10, 2002 + 20 years = September 10, 2022
- Continuation of application 16/930,194, filed Jul 15, 2020, issued as US 11,413,045
- Continuation of application 15/358,483, filed Nov 22, 2016, issued as US 10,758,239
- Continuation of application 13/938,025, filed Jul 9, 2013, issued as US 9,533,116
- Continuation of application 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
- Continuation-in-part of application 11/685,008, filed Mar 12, 2007
- Continuation-in-part of application 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
- Continuation-in-part of application 10/241,733, filed Sep 10, 2002
- Continuation-in-part of application 11/685,008, filed Mar 12, 2007
- Continuation-in-part of application 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
- Continuation of application 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
- Continuation-in-part of application 11/685,008, filed Mar 12, 2007
- Continuation-in-part of application 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
- Continuation of application 13/938,025, filed Jul 9, 2013, issued as US 9,533,116
- Continuation of application 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
- Continuation-in-part of application 11/685,008, filed Mar 12, 2007
- Continuation-in-part of application 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
- Continuation of application 15/358,483, filed Nov 22, 2016, issued as US 10,758,239
- Continuation of application 13/938,025, filed Jul 9, 2013, issued as US 9,533,116
- Continuation of application 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
- Continuation-in-part of application 11/685,008, filed Mar 12, 2007
- Continuation-in-part of application 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
- PRO60/699,289 — Provisional — not used for base term
- PRO60/696,940 — Provisional — not used for base term
- PRO60/645,711 — Provisional — not used for base term
- PRO60/318,539 — Provisional — not used for base term
- PRO60/318,539 — Provisional — not used for base term
- PRO60/699,289 — Provisional — not used for base term
- PRO60/696,940 — Provisional — not used for base term
- PRO60/645,711 — Provisional — not used for base term
- PRO60/645,711 — Provisional — not used for base term
- PRO60/696,940 — Provisional — not used for base term
- PRO60/699,289 — Provisional — not used for base term
- PRO60/645,711 — Provisional — not used for base term
- PRO60/696,940 — Provisional — not used for base term
- PRO60/699,289 — Provisional — not used for base term
- PRO60/645,711 — Provisional — not used for base term
- PRO60/696,940 — Provisional — not used for base term
- PRO60/699,289 — Provisional — not used for base term
- PRO60/645,711 — Provisional — not used for base term
- PRO60/696,940 — Provisional — not used for base term
- PRO60/699,289 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to September 10, 2022
US 8,496,006· Application 12/820,547Capping patent
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
- Filing date
- Jun 22, 2010
- Earliest effective filing
- Sep 10, 2002
- Issue date
- Jul 30, 2013
- PTA
- +356 days
- Calculated expiration
- Sep 1, 2023
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation-in-part of 10/241,733, filed Sep 10, 2002
Sep 10, 2002 + 20y + 356d PTA = Sep 1, 2023
US 9,533,116· Application 13/938,025Capping patent
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
- Filing date
- Jul 9, 2013
- Earliest effective filing
- Sep 10, 2002
- Issue date
- Jan 3, 2017
- PTA
- +135 days
- Calculated expiration
- Jan 23, 2023
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation-in-part of 10/241,733, filed Sep 10, 2002
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Sep 10, 2002 + 20y + 135d PTA = Jan 23, 2023
US 10,758,239· Application 15/358,483
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
- Filing date
- Nov 22, 2016
- Earliest effective filing
- Sep 10, 2002
- Issue date
- Sep 1, 2020
- PTA
- +830 days
- Calculated expiration
- Dec 18, 2024
Continuation of 13/938,025, filed Jul 9, 2013, issued as US 9,533,116
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation-in-part of 10/241,733, filed Sep 10, 2002
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Sep 10, 2002 + 20y + 830d PTA = Dec 18, 2024
US 11,413,045· Application 16/930,194
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
- Filing date
- Jul 15, 2020
- Earliest effective filing
- Sep 10, 2002
- Issue date
- Aug 16, 2022
- PTA
- +184 days
- Calculated expiration
- Mar 13, 2023
Continuation of 15/358,483, filed Nov 22, 2016, issued as US 10,758,239
Continuation of 13/938,025, filed Jul 9, 2013, issued as US 9,533,116
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation-in-part of 10/241,733, filed Sep 10, 2002
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation of 13/938,025, filed Jul 9, 2013, issued as US 9,533,116
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Sep 10, 2002 + 20y + 184d PTA = Mar 13, 2023
US 11,883,029· Application 17/867,990(from application 17/867,990)Capping patent
Methods and devices for passive residual lung volume reduction and functional lung volume expansion
- Filing date
- Jul 19, 2022
- Earliest effective filing
- Sep 10, 2002
- Issue date
- Jan 30, 2024
- PTA
- 0 days
- Calculated expiration
- Sep 10, 2022
Continuation of 16/930,194, filed Jul 15, 2020, issued as US 11,413,045
Continuation of 15/358,483, filed Nov 22, 2016, issued as US 10,758,239
Continuation of 13/938,025, filed Jul 9, 2013, issued as US 9,533,116
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation-in-part of 10/241,733, filed Sep 10, 2002
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation of 13/938,025, filed Jul 9, 2013, issued as US 9,533,116
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Continuation of 15/358,483, filed Nov 22, 2016, issued as US 10,758,239
Continuation of 13/938,025, filed Jul 9, 2013, issued as US 9,533,116
Continuation of 12/820,547, filed Jun 22, 2010, issued as US 8,496,006
Continuation-in-part of 11/685,008, filed Mar 12, 2007
Continuation-in-part of 11/296,951, filed Dec 7, 2005, issued as US 7,883,471
Sep 10, 2002 + 20y = Sep 10, 2022
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/867,990 · US 11,883,029
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 11,883,029: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11883029Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.